[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100647236":3},{"organization":4,"armGroups":7,"interventions":52,"overallOfficials":58,"centralContacts":63,"locations":69,"responsibleParty":83,"collaborators":58,"id":85,"slug":86,"hasResults":87,"nctId":88,"briefTitle":89,"officialTitle":90,"acronym":58,"eligibilityCriteria":91,"healthyVolunteers":87,"sex":92,"minAge":93,"maxAge":94,"enrollmentInfo":95,"targetDuration":58,"studyType":98,"phases":99,"briefSummary":101,"conditions":102,"keywords":58,"overallStatus":104,"whyStopped":58,"lastUpdateSubmitDate":105,"lastUpdatePostDateStruct":106,"startDateStruct":109,"completionDateStruct":111,"leadSponsor":113,"locationsCount":114},{"fullName":5,"class":6},"Ain Shams University","OTHER",[8,14,20,24,28,32,36,40,44,48],{"label":9,"type":10,"description":11,"interventionNames":12},"Non_obese + NE 0 mic\u002Fkg\u002Fmin","PLACEBO_COMPARATOR","Non\\_obese Patients BMI \\\u003C30 kg\u002Fm2 receiving placebo (normal saline )infusion after spinal anesthesia.",[13],"Drug: Normal Saline",{"label":15,"type":16,"description":17,"interventionNames":18},"Non_obese + NE 0.025mic\u002Fkg\u002Fmin","ACTIVE_COMPARATOR","Non\\_obese Patients BMI \\\u003C30 kg\u002Fm2 receiving prophylactic nor epinephrine infusion at 0.025mic\u002Fkg\u002Fmin after spinal anesthesia.",[19],"Drug: Nor-epinephrine",{"label":21,"type":16,"description":22,"interventionNames":23},"Non_obese + NE 0.05mic\u002Fkg\u002Fmin","Non\\_obese Patients BMI \\\u003C30 kg\u002Fm2 receiving prophylactic nor epinephrine infusion at 0.05mic\u002Fkg\u002Fmin after spinal anesthesia.",[19],{"label":25,"type":16,"description":26,"interventionNames":27},"Non_obese + NE 0.075mic\u002Fkg\u002Fmin","Non\\_obese Patients BMI \\\u003C30 kg\u002Fm2 receiving prophylactic nor epinephrine infusion at 0.075mic\u002Fkg\u002Fmin after spinal anesthesia.",[19],{"label":29,"type":16,"description":30,"interventionNames":31},"Non_obese + NE 0.1mic\u002Fkg\u002Fmin","Non\\_obese Patients BMI \\\u003C30 kg\u002Fm2 receiving prophylactic nor epinephrine infusion at 0.1mic\u002Fkg\u002Fmin after spinal anesthesia.",[19],{"label":33,"type":10,"description":34,"interventionNames":35},"Obese + NE 0 mic\u002Fkg\u002Fmin","Obese Patients BMI \\>30 kg\u002Fm2 receiving placebo (normal saline )infusion after spinal anesthesia.",[13],{"label":37,"type":16,"description":38,"interventionNames":39},"Obese + NE 0.025 mic\u002Fkg\u002Fmin","Obese Patients BMI\\>30 kg\u002Fm2 receiving prophylactic nor epinephrine infusion at 0.025 mic\u002Fkg\u002Fmin after spinal anesthesia.",[19],{"label":41,"type":16,"description":42,"interventionNames":43},"Obese + NE 0.05 mic\u002Fkg\u002Fmin","Obese Patients BMI\\>30 kg\u002Fm2 receiving prophylactic nor epinephrine infusion at 0.05 mic\u002Fkg\u002Fmin after spinal anesthesia.",[19],{"label":45,"type":16,"description":46,"interventionNames":47},"Obese + NE 0.075 mic\u002Fkg\u002Fmin","Obese Patients BMI\\>30 kg\u002Fm2 receiving prophylactic nor epinephrine infusion at 0.075 mic\u002Fkg\u002Fmin after spinal anesthesia.",[19],{"label":49,"type":16,"description":50,"interventionNames":51},"Obese + NE 0.1 mic\u002Fkg\u002Fmin","Obese Patients BMI\\>30 kg\u002Fm2 receiving prophylactic nor epinephrine infusion at 0.1 mic\u002Fkg\u002Fmin after spinal anesthesia.",[19],[53,59],{"type":54,"name":55,"description":56,"armGroupLabels":57,"otherNames":58},"DRUG","Nor-epinephrine","norepinephrine infusion doses ( 0.025, 0.05, and 0.075, 0.1 mic\u002Fkg\u002Fmin) post spinal anesthesia .",[15,21,25,29,37,41,45,49],null,{"type":54,"name":60,"description":61,"armGroupLabels":62,"otherNames":58},"Normal Saline","normal saline infusion post spinal anesthesia .",[9,33],[64],{"name":65,"role":66,"phone":67,"phoneExt":58,"email":68},"Merna M.k. Mohy, M.SC","CONTACT","+201065606283","mernakamal77@gmail.com",[70],{"facility":71,"status":58,"city":72,"state":73,"zip":74,"country":75,"countryCode":76,"cosmosGeoPoint":77,"geoPoint":82,"contacts":58},"Ain Shams","Cairo","Abbasia","00202","Egypt","EG",{"type":78,"coordinates":79},"Point",[80,81],31.24967,30.06263,{"lat":81,"lon":80},{"type":84,"investigatorFullName":58,"investigatorTitle":58,"investigatorAffiliation":58,"oldNameTitle":58,"oldOrganization":58},"SPONSOR","100647236","this-is-a-study-that-aims-to-estimate-the-effect-of-maternal-body-mass-index-on-the-prophylactic-dose-of-norepinephrine-infusion-for-preventing-hypotension-in-parturient-after-spinal-anesthesia-100647236",false,"NCT07706426","This is a Study That Aims to Estimate the Effect of Maternal Body Mass Index on the Prophylactic Dose of Norepinephrine Infusion for Preventing Hypotension in Parturient After Spinal Anesthesia","Effect of Maternal Body Mass Index on the Prophylactic Dose of Norepinephrine Infusion for Preventing Hypotension in Parturient After Spinal Anesthesia","Inclusion Criteria:\n\n* A normal singleton pregnancy with a gestational age of ≥ 37 weeks. 18-40 years old pregnant women scheduled for elective C\u002FS under spinal anesthesia.\n\nExclusion Criteria:\n\n* Any absolute contraindication to spinal block, Neurological or cardiac disorder, Basal systolic blood pressure above 140 mmHg or below 100 mmHg, Peripartum bleeding or emergent situations both for fetus and mother, Those who refused to participate in the study were excluded Known fetal abnormality, intrauterine growth restriction, Obstetric complication (ruptured membranes, placenta previa, placental abruption),","FEMALE","18 Years","40 Years",{"count":96,"type":97},80,"ESTIMATED","INTERVENTIONAL",[100],"NA","This is a randomized, double-blinded controlled study that aims to estimate the effect of maternal body mass index on the prophylactic dose of norepinephrine infusion for preventing hypotension in parturient after spinal anesthesia.",[103],"Post Spinal Anaesthesia Hypotension","NOT_YET_RECRUITING","2026-07-11",{"date":107,"type":108},"2026-07-15","ACTUAL",{"date":110,"type":97},"2026-07-09",{"date":112,"type":97},"2027-04-20",{"name":5,"class":6},1]